Crossref
Oxymatrine Mitigates Metabolic Syndrome-Induced Renal Damage Via Upregulation of Nrf2/HO-1 Signaling Pathway in Rats
The Egyptian Journal of Hospital Medicine · 01.04.2026 · 103 (1) · 1529-1536
DOI: 10.21608/ejhm.2026.496144 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.04.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Oxymatrine Mitigates Metabolic Syndrome-Induced Renal Damage Via Upregulation of Nrf2/HO-1 Signaling Pathway in Rats. The Egyptian Journal of Hospital Medicine, 103(1), 1529-1536. https://doi.org/10.21608/ejhm.2026.496144
Vancouver
Oxymatrine Mitigates Metabolic Syndrome-Induced Renal Damage Via Upregulation of Nrf2/HO-1 Signaling Pathway in Rats. The Egyptian Journal of Hospital Medicine. 2026;103(1):1529-1536. doi:10.21608/ejhm.2026.496144
BibTeX
@article{euvimed2026,
title = {Oxymatrine Mitigates Metabolic Syndrome-Induced Renal Damage Via Upregulation of Nrf2/HO-1 Signaling Pathway in Rats},
journal = {The Egyptian Journal of Hospital Medicine},
year = {2026},
volume = {103},
number = {1},
pages = {1529--1536},
doi = {10.21608/ejhm.2026.496144}
}
EUVIMED